West Pharmaceutical Services Inc (WST)
366.66
-1.69
(-0.46%)
USD |
NYSE |
May 08, 16:00
366.90
+0.24
(+0.06%)
After-Hours: 20:00
West Pharmaceutical Services Cash from Operations (TTM): 756.60M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 756.60M |
December 31, 2023 | 776.50M |
September 30, 2023 | 768.20M |
June 30, 2023 | 707.00M |
March 31, 2023 | 710.90M |
December 31, 2022 | 724.00M |
September 30, 2022 | 654.00M |
June 30, 2022 | 675.20M |
March 31, 2022 | 646.50M |
December 31, 2021 | 584.00M |
September 30, 2021 | 571.90M |
June 30, 2021 | 500.40M |
March 31, 2021 | 504.10M |
December 31, 2020 | 472.50M |
September 30, 2020 | 430.20M |
June 30, 2020 | 419.70M |
March 31, 2020 | 376.70M |
December 31, 2019 | 367.20M |
September 30, 2019 | 334.00M |
June 30, 2019 | 314.30M |
March 31, 2019 | 291.20M |
December 31, 2018 | 288.60M |
September 30, 2018 | 296.90M |
June 30, 2018 | 284.30M |
March 31, 2018 | 287.60M |
Date | Value |
---|---|
December 31, 2017 | 263.30M |
September 30, 2017 | 253.60M |
June 30, 2017 | 246.20M |
March 31, 2017 | 237.10M |
December 31, 2016 | 219.40M |
September 30, 2016 | 215.60M |
June 30, 2016 | 216.00M |
March 31, 2016 | 217.30M |
December 31, 2015 | 212.40M |
September 30, 2015 | 190.40M |
June 30, 2015 | 185.50M |
March 31, 2015 | 172.20M |
December 31, 2014 | 182.90M |
September 30, 2014 | 205.70M |
June 30, 2014 | 195.10M |
March 31, 2014 | 210.40M |
December 31, 2013 | 220.50M |
September 30, 2013 | 221.50M |
June 30, 2013 | 219.80M |
March 31, 2013 | 192.50M |
December 31, 2012 | 187.40M |
September 30, 2012 | 159.40M |
June 30, 2012 | 147.50M |
March 31, 2012 | 135.00M |
December 31, 2011 | 130.70M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
314.30M
Minimum
Jun 2019
776.50M
Maximum
Dec 2023
564.70M
Average
577.95M
Median
Cash from Operations (TTM) Benchmarks
Becton Dickinson & Co | 3.761B |
Abbott Laboratories | 7.143B |
Masimo Corp | 94.10M |
Merit Medical Systems Inc | 166.82M |
Insulet Corp | 145.70M |